Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 4 (4), 307-20

Cellular Processing of Platinum Anticancer Drugs

Affiliations
Review

Cellular Processing of Platinum Anticancer Drugs

Dong Wang et al. Nat Rev Drug Discov.

Abstract

Cisplatin, carboplatin and oxaliplatin are platinum-based drugs that are widely used in cancer chemotherapy. Platinum-DNA adducts, which are formed following uptake of the drug into the nucleus of cells, activate several cellular processes that mediate the cytotoxicity of these platinum drugs. This review focuses on recently discovered cellular pathways that are activated in response to cisplatin, including those involved in regulating drug uptake, the signalling of DNA damage, cell-cycle checkpoints and arrest, DNA repair and cell death. Such knowledge of the cellular processing of cisplatin adducts with DNA provides valuable clues for the rational design of more efficient platinum-based drugs as well as the development of new therapeutic strategies.

Similar articles

See all similar articles

Cited by 700 PubMed Central articles

See all "Cited by" articles

Publication types

Substances

LinkOut - more resources

Feedback